Literature DB >> 28797463

Validation and comparison of the 7th and 8th edition of AJCC staging systems for non-metastatic nasopharyngeal carcinoma, and proposed staging systems from Hong Kong, Guangzhou, and Guangxi.

Pu-Yun OuYang1, Yao Xiao1, Kai-Yun You2, Lu-Ning Zhang3, Xiao-Wen Lan1, Xiao-Min Zhang1, Fang-Yun Xie4.   

Abstract

OBJECTIVES: We aimed to validate and compare the 7th and 8th edition of AJCC staging systems for non-metastatic nasopharyngeal carcinoma, and proposed staging systems from Hong Kong, Guangzhou, and Guangxi.
MATERIALS AND METHODS: We retrospectively included 899 patients treated between November 5, 2002 and May 27, 2010. Separation and discrimination of each staging system in overall survival were primarily compared.
RESULTS: Compared with the 7th AJCC, the 8th AJCC and all proposed staging systems well separated across T-classification. T-classification from Guangzhou seemed to perform best in discrimination (C-index 0.6454), followed by the 8th AJCC (0.6451), the 7th AJCC (0.6386), Hong Kong (0.6376) and Guangxi (0.5889). For N-classification, no staging systems improved the weakness of the 7th AJCC in separating N2 and N1, except that suggestion from Guangzhou showed higher potential (P=0.096). Besides, N-classification from Guangzhou had a C-index of 0.6444, larger than that of the 8th AJCC (0.6235), the 7th AJCC (0.6179), Hong Kong (0.6175) and Guangxi (0.6175). Accordingly, stage group of staging system from Guangzhou showed higher discrimination (C-index 0.6839), compared with the 8th AJCC (0.6791), the 7th AJCC (0.6766), Hong Kong (0.6765) and Guangxi (0.6688), despite that stage I and II remained inseparable (P=0.322).
CONCLUSIONS: The 8th AJCC staging system appeared to be better than the 7th AJCC. But the proposed staging system from Guangzhou was more likely to improve the separation and discrimination abilities.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  AJCC; Cancer staging; Intensity-modulated radiotherapy; Nasopharyngeal carcinoma

Mesh:

Year:  2017        PMID: 28797463     DOI: 10.1016/j.oraloncology.2017.07.011

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  10 in total

1.  Nodal grouping in nasopharyngeal carcinoma: prognostic significance, N classification, and a marker for the identification of candidates for induction chemotherapy.

Authors:  Yifei Liu; Shenghuan Chen; Annan Dong; Fei Ai; Tingting Quan; Chunyan Cui; Jian Zhou; Shaobo Liang; Jiamin Wang; Shunxin Wang; Ling Hua; Shuoyu Xu; Mingyuan Chen; Ying Sun; Haojiang Li; Lizhi Liu
Journal:  Eur Radiol       Date:  2019-12-06       Impact factor: 5.315

2.  Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa.

Authors:  Cheng-Long Huang; Rui Guo; Jun-Yan Li; Cheng Xu; Yan-Ping Mao; Li Tian; Ai-Hua Lin; Ying Sun; Jun Ma; Ling-Long Tang
Journal:  Eur Radiol       Date:  2019-10-24       Impact factor: 5.315

3.  A novel prognostic model predicts overall survival in patients with nasopharyngeal carcinoma based on clinical features and blood biomarkers.

Authors:  Changchun Lai; Chunning Zhang; Hualiang Lv; Hanqing Huang; Xia Ke; Chuchan Zhou; Hao Chen; Shulin Chen; Lei Zhou
Journal:  Cancer Med       Date:  2021-05-11       Impact factor: 4.452

4.  MACC1 Is Associated With Epithelial-Mesenchymal Transition and Can Predict Poor Prognosis in Nasopharyngeal Carcinoma.

Authors:  Hao Cheng; Linxiang Zhou; Yalan Long; Juanjuan Xiang; Longhua Chen
Journal:  Front Oncol       Date:  2021-03-29       Impact factor: 6.244

5.  The Effect of Marital Status on Nasopharyngeal Carcinoma Survival: A Surveillance, Epidemiology and End Results Study.

Authors:  San-Gang Wu; Qing-Hong Zhang; Wen-Wen Zhang; Jia-Yuan Sun; Qin Lin; Zhen-Yu He
Journal:  J Cancer       Date:  2018-04-27       Impact factor: 4.207

6.  Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.

Authors:  Xing-Li Yang; Yan Wang; Shao-Bo Liang; Sha-Sha He; Dan-Ming Chen; Hai-Yang Chen; Li-Xia Lu; Yong Chen
Journal:  BMC Cancer       Date:  2018-05-29       Impact factor: 4.430

7.  Quantitative Metastatic Lymph Node Regions on Magnetic Resonance Imaging Are Superior to AJCC N Classification for the Prognosis of Nasopharyngeal Carcinoma.

Authors:  Xin Zhou; Xiaomin Ou; Youqi Yang; Tingting Xu; Chunying Shen; Jianhui Ding; Chaosu Hu
Journal:  J Oncol       Date:  2018-12-02       Impact factor: 4.375

8.  Comparing the 7th and 8th editions of UICC/AJCC staging system for nasopharyngeal carcinoma in the IMRT era.

Authors:  Tao He; Ruo-Nan Yan; Hua-Ying Chen; Yuan-Yuan Zeng; Zhong-Zheng Xiang; Fang Liu; Bian-Fei Shao; Jia-Chun Ma; Xi-Ran Wang; Lei Liu
Journal:  BMC Cancer       Date:  2021-03-30       Impact factor: 4.430

9.  A Nomogram Based on Serum Biomarkers and Clinical Characteristics to Predict Survival in Patients With Non-Metastatic Nasopharyngeal Carcinoma.

Authors:  Qing-Jie Li; Yan-Ping Mao; Rui Guo; Cheng-Long Huang; Xue-Liang Fang; Jun Ma; Ling-Long Tang; Lei Chen
Journal:  Front Oncol       Date:  2020-12-10       Impact factor: 6.244

10.  Selection and validation of chemotherapy beneficiaries among elderly nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiation therapy (IMRT): a large real-world study.

Authors:  Yan-Ling Wu; Kai-Bin Yang; Ying Huang; Jing-Rong Shi; Qing-Shui He; Lei Chen; Wen-Fei Li; Xiao-Dan Huang; Li Lin; Yu-Pei Chen; Yan-Ping Mao; Ling-Long Tang; Jun Ma
Journal:  Radiat Oncol       Date:  2022-08-08       Impact factor: 4.309

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.